Skip to main content
logo
Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
20.09
+0.34 (1.72%)
At close: Jul 3, 2025, 1:00 PM
19.05
-1.04 (-5.18%)
After-hours: Jul 3, 2025, 4:15 PM EDT

Neurogene Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.930.93---
Cost of Revenue
65.1360.8244.3947.5142.26
Gross Profit
-64.2-59.89-44.39-47.51-42.26
Selling, General & Admin
25.5322.6111.199.018.27
Operating Expenses
25.5322.6111.199.018.27
Operating Income
-89.74-82.51-55.58-56.52-50.53
Interest Expense
-0.01-0.01-0.01-0-
Interest & Investment Income
9.358.472.951.340.02
Other Non Operating Income (Expenses)
-0.47-0.99-0.03-0.01-
EBT Excluding Unusual Items
-80.86-75.04-52.67-55.19-50.52
Asset Writedown
-0.01-0.1---
Other Unusual Items
--16.36--
Pretax Income
-80.87-75.14-36.32-55.19-50.52
Net Income
-80.87-75.14-36.32-55.19-50.52
Preferred Dividends & Other Adjustments
---49.97--
Net Income to Common
-80.87-75.1413.65-55.19-50.52
Shares Outstanding (Basic)
1918004
Shares Outstanding (Diluted)
1918504
Shares Change (YoY)
111.87%277.22%1080.37%-90.26%-
EPS (Basic)
-4.35-4.2827.76-139.88-12.47
EPS (Diluted)
-4.35-4.282.93-139.88-12.47
Free Cash Flow
-71.25-71.41-51.74-55.05-64.77
Free Cash Flow Per Share
-3.83-4.07-11.11-139.54-15.99
Operating Margin
-9701.19%-8919.46%---
Profit Margin
-8742.70%-8123.68%---
Free Cash Flow Margin
-7702.70%-7720.11%---
EBITDA
-86.55-79.26-52.29-53.32-49.59
D&A For EBITDA
3.183.253.33.20.95
EBIT
-89.74-82.51-55.58-56.52-50.53
Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q